These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 27281861)

  • 21. The role of vaginal estrogen in the treatment of urogenital dysfunction in postmenopausal women.
    Bernier F; Jenkins P
    Urol Nurs; 1997 Sep; 17(3):92-5. PubMed ID: 9349043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genitourinary Changes with Aging.
    Mitchell CM; Waetjen LE
    Obstet Gynecol Clin North Am; 2018 Dec; 45(4):737-750. PubMed ID: 30401554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Managing urogenital atrophy.
    Palacios S
    Maturitas; 2009 Aug; 63(4):315-8. PubMed ID: 19493638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Approach to the patient with menopausal symptoms.
    Martin KA; Manson JE
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4567-75. PubMed ID: 19056840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline.
    Stuenkel CA; Davis SR; Gompel A; Lumsden MA; Murad MH; Pinkerton JV; Santen RJ
    J Clin Endocrinol Metab; 2015 Nov; 100(11):3975-4011. PubMed ID: 26444994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical practice. Management of menopausal symptoms.
    Grady D
    N Engl J Med; 2006 Nov; 355(22):2338-47. PubMed ID: 17135587
    [No Abstract]   [Full Text] [Related]  

  • 27. The management of lower urogenital changes in the menopause.
    Singh S; van Herwijnen I; Phillips C
    Menopause Int; 2013 Jun; 19(2):77-81. PubMed ID: 23778562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Menopause.
    Takahashi TA; Johnson KM
    Med Clin North Am; 2015 May; 99(3):521-34. PubMed ID: 25841598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genitourinary syndrome of the menopause--dawn of a new era?
    Panay N
    Climacteric; 2015; 18 Suppl 1():13-7. PubMed ID: 26366795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of local estrogen therapy in the management of pelvic floor disorders.
    Tzur T; Yohai D; Weintraub AY
    Climacteric; 2016 Apr; 19(2):162-71. PubMed ID: 26830033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaginal oestrogen therapy after breast cancer: is it safe?
    Ponzone R; Biglia N; Jacomuzzi ME; Maggiorotto F; Mariani L; Sismondi P
    Eur J Cancer; 2005 Nov; 41(17):2673-81. PubMed ID: 16239103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet.
    Weisberg E; Ayton R; Darling G; Farrell E; Murkies A; O'Neill S; Kirkegard Y; Fraser IS
    Climacteric; 2005 Mar; 8(1):83-92. PubMed ID: 15804736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urogenital disorders associated with oestrogen deficiency: the role of promestriene as topical oestrogen therapy.
    Santos I; Clissold S
    Gynecol Endocrinol; 2010 Sep; 26(9):644-51. PubMed ID: 20374067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genitourinary Syndrome of Menopause in Breast Cancer Survivors: Are We Facing New and Safe Hopes?
    Biglia N; Bounous VE; Sgro LG; D'Alonzo M; Pecchio S; Nappi RE
    Clin Breast Cancer; 2015 Dec; 15(6):413-20. PubMed ID: 26198332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of two estrogen preparations (a combined contraceptive pill versus conjugated estrogen cream) intravaginally to treat urogenital symptoms in postmenopausal Thai women: a comparative study.
    Chompootaweep S; Nunthapisud P; Trivijitsilp P; Sentrakul P; Dusitsin N
    Clin Pharmacol Ther; 1998 Aug; 64(2):204-10. PubMed ID: 9728901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Urogenital complaints: value of systemic estrogen therapy].
    Hänggi W; Dörflinger A
    Praxis (Bern 1994); 1997 Aug; 86(33):1260-3. PubMed ID: 9381012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogens and the urogenital tract. Studies on steroid hormone receptors and a clinical study on a new estradiol-releasing vaginal ring.
    Smith P
    Acta Obstet Gynecol Scand Suppl; 1993; 157():1-26. PubMed ID: 8393609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of menopausal symptoms in breast cancer patients.
    Loibl S; Lintermans A; Dieudonné AS; Neven P
    Maturitas; 2011 Feb; 68(2):148-54. PubMed ID: 21185135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and tolerability of local estrogen therapy for urogenital atrophy.
    Archer DF
    Menopause; 2010; 17(1):194-203. PubMed ID: 19602990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaginal estrogen use for genitourinary symptoms in women with a history of uterine, cervical, or ovarian carcinoma.
    Chambers LM; Herrmann A; Michener CM; Ferrando CA; Ricci S
    Int J Gynecol Cancer; 2020 Apr; 30(4):515-524. PubMed ID: 32075898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.